What Happened?
Shares of life sciences company Avantor (NYSE:AVTR) fell 8% in the afternoon session after the company announced that it has appointed Emmanuel Ligner as its new President and Chief Executive Officer, effective August 18, 2025.
Ligner will succeed Michael Stubblefield, whose departure was previously announced. The news of a leadership change, particularly one that brings in a CEO with no prior public company experience, appears to have created uncertainty among investors. Wolfe Research noted that while Ligner's extensive experience in bioprocessing is a strategic fit for Avantor, his lack of public company CEO experience might lead to investor scrutiny. The firm also highlighted that the absence of updated financial guidance alongside the announcement would likely "raise questions" for investors, who often react negatively to a lack of forward-looking statements during executive transitions.,.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Avantor? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Avantor’s shares are somewhat volatile and have had 13 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 3 months ago when the stock dropped 21.2% on the news that the company reported a weak first-quarter 2025 performance, as its organic revenue and total sales both missed Wall Street's expectations. Sales dropped 6% from a year ago, reflecting softness across both major business segments. Lab Solutions declined 8% while Bioscience Production slipped slightly. Encouragingly, management raised its cost savings target to $400 million by 2027 and signaled urgency to fix performance issues in the Lab Solutions segment. Still, this was a softer quarter.
Avantor is down 42.3% since the beginning of the year, and at $12.23 per share, it is trading 55.9% below its 52-week high of $27.70 from September 2024. Investors who bought $1,000 worth of Avantor’s shares 5 years ago would now be looking at an investment worth $655.14.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.